Batches of the insulin medicine NovoMix 30 FlexPen and Penfill to be recalled

View source ↗

Summary

The European Medicines Agency reports a recall of batches of NovoMix 30 FlexPen and NovoMix 30 FlexPen PenFill insulin pens due to quality concerns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• NovoMix 30 FlexPen (insulin lispro protamine suspension)
• NovoMix 30 FlexPen PenFill (insulin aspart)